Theresa Mary Conway, PA | |
300 Community Dr, Manhasset, NY 11030-3816 | |
(516) 662-5100 | |
Not Available |
Full Name | Theresa Mary Conway |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Location | 300 Community Dr, Manhasset, New York |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003326232 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 021260 (New York) | Secondary |
363A00000X | Physician Assistant | 021260 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Theresa Mary Conway, PA 225 Park Ave, Williston Park, NY 11596-1133 Ph: () - | Theresa Mary Conway, PA 300 Community Dr, Manhasset, NY 11030-3816 Ph: (516) 662-5100 |
News Archive
University of Cincinnati (UC) analysis of 10 years of data from local kidney transplant patients shows that patients removed from a corticosteroid regimen shortly after surgery have better graft survival rates, better survival rates and fewer cardiovascular events than patients kept on the traditional regimen of long-term steroids.
With reports that ongoing negotiations between India and the European Union are expected to end in a free-trade agreement "by the end of August," Inter Press Service examines the concerns among drug manufacturers and exporters over how the agreement might reduce growth in India's generic medicines industry.
The Ohio State University has signed an agreement with the Sarawak Biodiversity Centre in Malaysia to collaborate on the further development and commercialization of a promising anticancer agent derived from a tropical tree that grows on the island of Borneo.
A small study from Johns Hopkins adds to the growing body of evidence that red blood cells stored longer than three weeks begin to lose the capacity to deliver oxygen-rich cells where they may be most needed.
Investigators at the University of California, San Diego School of Medicine have developed a new drug called nitrosyl-cobinamide.
› Verified 2 days ago